BGM (BGM Group) Marketable Securities: $1.00 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGM BGM Group Ltd BGM
37 GF Score
Price $0.28
GF Value $0.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is BGM Group Marketable Securities?

BGM Group BGM +0.68% 37 Marketable Securities is $1.00 Mil as of Sep. 2025. GuruFocus rates BGM with a GF Score™ of 37/100 and a GF Value™ of $0.26 (Fairly Valued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. BGM Group's Marketable Securities for the quarter that ended in Sep. 2025 was $1.00 Mil.

BGM Group's annual Marketable Securities declined from Sep. 2023 ($14.94 Mil) to Sep. 2024 ($8.32 Mil) and declined from Sep. 2024 ($8.32 Mil) to Sep. 2025 ($1.00 Mil).

BGM Group  (NAS:BGM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

BGM Group Marketable Securities Related Terms

BGM Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for BGM Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group Marketable Securities Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 14.94 8.32 1.00

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.94 15.01 8.32 4.89 1.00
BGM
37GF Score
BGM Group Ltd BGM
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BGM Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $1.00 Mil mean?
BGM Group (BGM) has a Marketable Securities of $1.00 Mil as of Sep. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on BGM Group and its competitors.
Is BGM Group's Marketable Securities too high?
BGM Group's current Marketable Securities is $1.00 Mil. Overall, BGM Group has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Marketable Securities compare to CPIX and ADCT?
BGM Group's Marketable Securities of $1.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on BGM Group and its competitors. BGM Group's current Marketable Securities is $1.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Fairly Valued. The stock's GF Value™ is $0.26, compared to a current price of $0.28 — trading 8.5% above its estimated fair value. The current Marketable Securities is $1.00 Mil. BGM Group's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For BGM Group (BGM), the current Marketable Securities is $1.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be overvalued. The current stock price of $0.28 is trading 8.5% above its estimated GF Value™ of $0.26. GuruFocus considers BGM Group to be Fairly Valued.

Key valuation signals for BGM:

  • Marketable Securities: $1.00 Mil
  • GF Value™: $0.26 vs. price of $0.28 (8.5% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
37GF Score

Get the complete analysis for BGM

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.26
GF Value